Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced the appointment of the Company's Nomination Committee.

We aim to build confidence in the safety and reliability of payment service providers’ services while protecting end users from specific risks. We’re taking steps to better understand the impacts of ...